Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Arcutis Biotherapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +11 vs. Q1 2022
- Shares held
- 49.1M
- +790.2K (+1.6%) vs. Q1 2022
- Total value
- $1.05B
- +$116.5M (+12.5%) vs. Q1 2022
- New holders
- 23
- 52 more added
- Sold out
- 12
- 19 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 629,754 | $13.4M | 0.02% | +20,106+3.3% | Added |
| GW&K Investment Management, LLC | 676,678 | $14.4M | 0.16% | +464,178+218.4% | Added |
| Franklin Resources Inc | 793,896 | $16.9M | 0.01% | +134,060+20.3% | Added |
| EcoR1 Capital, LLC | 895,503 | $19.1M | 0.66% | 00.0% | Unchanged |
| Pictet Asset Management SA | 922,894 | $19.7M | 0.03% | +922,894 | New |
| Logos Global Management LP | 1,000,000 | $21.3M | 3.91% | −500,000−33.3% | Reduced |
| State Street Corp | 1,396,425 | $29.8M | 0.00% | +206,925+17.4% | Added |
| Polar Capital Holdings Plc | 1,405,796 | $30.0M | 0.23% | −378,209−21.2% | Reduced |
| Vanguard Group Inc | 1,798,663 | $38.3M | 0.00% | +267,565+17.5% | Added |
| Point72 Asset Management, L.P. | 1,987,431 | $42.4M | 0.20% | +289,582+17.1% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $63.9M | 7.50% | −979,292−24.6% | Reduced |
| BlackRock Inc. | 4,578,153 | $97.6M | 0.00% | +262,351+6.1% | Added |
| OrbiMed Advisors LLC | 4,781,646 | $101.9M | 1.98% | −1,292,204−21.3% | Reduced |
| FMR LLC | 7,712,680 | $164.4M | 0.02% | +155,087+2.1% | Added |
| Frazier Life Sciences Management, L.P. | 8,434,232 | $179.7M | 16.96% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −100,126−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −75,553−100.0% | Sold out |
| Hamilton Lane Advisors LLC | 0 | $0 | 0.00% | −52,347−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −27,851−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −26,257−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −25,729−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,192−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −18,372−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −17,996−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,398−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −10,401−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |